JAVMA news
Board debates policy points on medicinal products
Thorny issues surrounding the appropriate use of medicinal products—and how to handle adverse events—prompted discussion during the Executive Board…
AVMA news
EPA, FDA weigh oversight overhaul for animal parasite products
Two federal agencies are considering transferring oversight of some 600 products from the Environmental Protection Agency (EPA) to the Food and Drug…
policy
Sale of human-label drug products to veterinarians
Because there are a limited number of drugs labeled for use in animals, veterinarians need to have access to human-labeled prescription drugs to…
JAVMA news
Class I recall issued for digoxin product
Veterinarians who use the human drug Digitek (digoxin tablets, USP, all strengths) to treat their patients should be aware that a Class I
JAVMA news
A time of transition at the FDA Center for Veterinary Medicine
Dr. Stephen F. Sundlof became the director of the FDA Center for Food Safety and Applied Nutrition, effective Jan. 7, after serving for more than a…
policy
UNDER REVIEWJudicious therapeutic use of antimicrobials in aquatic animal medicine
Aquatic animal veterinarians should use all therapeutants, including antimicrobials, judiciously to restore aquatic animal health, ensure continued…
AVMA news
Addressing global inequities in access to essential medicines
The World Veterinary Association (WVA) and the World Small Animal Veterinary Association (WSAVA) are taking steps to improve the global availability…
JAVMA news
Getting the right drug at the right dosage
Personalized medicine brings precision to drug treatment
JAVMA news
Horse deaths associated with unapproved drug
An unapproved clenbuterol product associated with two horse deaths in Louisiana has prompted the FDA to remind veterinarians and horse
AVMA news
Remaining medically important antimicrobials transitioning to prescription status
The Food and Drug Administration is reminding stakeholders that certain over-the-counter antimicrobial products for animals are transitioning to…
policy
Guidelines for use of autogenous biologics
Autogenous biological products may provide veterinarians a unique opportunity for control of certain infectious diseases when USDA-licensed commercial…
policy
AASV basic guidelines of judicious therapeutic use of antimicrobials in swine
The American Association of Swine Veterinarians and AVMA both support these guidelines on judicious therapeutic antimicrobial use in pork production.
JAVMA news
Veterinarians alerted to new directions for Eqvalan Liquid for horses
The Food and Drug Administration's Center for Veterinary Medicine is alerting veterinarians of revised directions for use of
policy
Development of emerging disease agent biologics
Development of emerging infectious disease biologics is essential for One Health. The AVMA supports the development of these products through…
AVMA news
FDA releases updated plan for antimicrobial stewardship in veterinary settings
The U.S. Food and Drug Administration’s Center for Veterinary Medicine on October 1 launched the latest phases of its ongoing plan to promote…
policy
Dietary Supplement Health and Education Act of 1994
The Dietary Supplement Health and Education Act of 1994, which defines dietary supplements for use in humans, does not apply to products intended for…
JAVMA news
FDA issues booklet reviewing information on animal health care needs
The Center for Veterinary Medicine within the Food and Drug Administration published a pamphlet in August titled "FDA and the Veterinarian."
FAQs about extralabel drug use
See answers to common questions about extra-label drug use by veterinarians and the Animal Medicinal Drug Use Clarification Act.
JAVMA news
FDA addressing shortage of drug for iron deficiency in neonatal pigs
The Food and Drug Administration Center for Veterinary Medicine is aware of a shortage of the injectable drug iron dextran
JAVMA news
FDA launches public-access database of animal drug approvals
The Food and Drug Administration's Center for Veterinary Medicine announced Oct. 1 the availability of a new database of approved animal drugs.
policy
Funding of the New Animal Drug Application (NADA) and Abbreviated New Animal Drug Application (ANADA) approval process
To help ensure adequate availability of veterinary drugs, the AVMA supports increased funding of the FDA Center for Veterinary Medicine for the NADA…
AVMA news
Unlawful xylazine receives more scrutiny to prevent inclusion in illegal drugs
Regulators and legislators are showing greater interest in xylazine, a prescription drug used in multiple sectors of clinical veterinary medicine,…
policy
AAAP guidelines for judicious therapeutic use of antimicrobials in poultry
The AVMA has endorsed these guidelines on judicious therapeutic antimicrobial use in poultry production, developed by the American Association of…
JAVMA news
Reminder: ECP not approved for use in animals
The Food and Drug Administration's Center for Veterinary Medicine has received reports that certain pharmacies and veterinarians have compounded…
policy
Veterinary ergonomic guidelines
Discover risk factors that could lead to musculo-skeletal injury, examples of related tasks in veterinary medicine, and what to do if you identify a…